Feburary 22, 2022 | Carlsbad, CA RCE, the AI med tech company developing point of care Troponin diagnostics, has announced the award of its first patent from the U. S. Patent and Trademark Office (USPTO). The patent details an optical based technique for the transdermal measurement of cardiac biomarkers. Diagnostic biomarkers are vital in determining…

Read more

Feb 19, 2022 | Atandra Burman Creativity is the act of conceiving something new, while Innovation is the act of putting that something new in practice. In other words, innovation is a direct manifestation of creative thinking. Creative thinking skills involve looking at a problem from different and creative angles, using the right tools to…

Read more

With over 300 million non-cardiac surgeries worldwide each year, more than 10 million patients develop major cardiac complications in the “perioperative” period. ie. within 30 days after non-cardiac surgeries. Perioperative cardiac complications can manifest as heart attacks, better referered to as perioperative myocardial infarctions (PMI). PMIs can be caused due to unstable coronary plaques (type…

Read more

Various cases in the hospitalization of patients with elevated Troponins have revealed certain false positives and false negatives with current lab assays in the measurement of cardiac Troponins, a biomarker specific to myocardial injury. It is prudent to raise awareness in the understanding, investigation and management of such scenarios in the best interest of patient…

Read more

RCE is 1 of 7 companies selected from around the world into TMCx Fall 2020 cohort. RCE is 1 of 7 companies selected from around the world into TMCx Fall 2020 cohort. With over 300 life science startups launched and $4.71B raised to date, TMC Innovation is at the forefront of advancing life sciences with…

Read more

Georgia Bio announces RCE as the winner of its 2020 GaBio Summit Pitch Rounds competition. Today, Georgia Bio announced RCE as the winner of its 2020 GaBio Summit Pitch Rounds competition.

Read more

A personal experience, and the could have been value of high sensitivity troponin in outcomes. Oct 29, 2020 | Jitto Titus It was just another day in Chennai, India, driving through the sea of vehicles when suddenly he felt some discomfort in his chest. As beads of sweat dripped down his brow, he clutched the…

Read more

RCE’s AI team trained a convolutional neural net on retrospective ECG data sets with ischemic vs non-ischemic classification. We then applied the held out model to prospective datasets from patients in cardiac observation unit. The accuracy of the model coupled with reliable data acquisition through a seamless ECG wearable is highly encouraging.  These initial efforts…

Read more

June 22, 2020 | Melissa Burman, MD, Shoheb Ali, MD COVID-19, or the corona virus disease of 2019, is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a deadly virus known to cause multisystem collapse, particularly acute and chronic cardiorespiratory complications. The pandemic has placed a silent pressure on institutions, requiring innovative…

Read more

RCE is excited to join the Advanced Technology Development Center (ATDC) accelerate program, Georgia Tech’s startup incubator.

Read more

RCE wins the 2019 SEMDA PitchRounds competition and works towards bringing a valuable diagnostic solution to market.  https://semda.net/spotlight-interview-semda-pitchrounds-winner-rce-technologies/

Read more

Jan 28, 2019 | RCE AI Critical heart events such as myocardial infarction(MI) or heart attack occur when blood flow to the heart is blocked, causing damage to heart muscle. Treatment usually involves intervention to widen the artery, allowing blood flow back to the heart muscles. In fact, early detection of MI events make a…

Read more